PEPE, Stefano

PEPE, Stefano  

Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED  

Mostra records
Risultati 1 - 20 di 183 (tempo di esecuzione: 0.043 secondi).
Titolo Data di pubblicazione Autore(i) File
5-Aza-2'-Deoxycitidine induces growth-inhibition and up-regulation of epidermal-growth factor receptor on human epithelial cancer-cells 1-gen-1994 M., Caraglia; A., Pinto; P., Correale; V., Zagonel; G., Genua; A., Leardi; Pepe, Stefano; A. R., Bianco; P., Tagliaferri
8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells 1-gen-1996 G., DI ISERNIA; F., Ciardiello; C., Sandomenico; Pepe, Stefano; A. R., Bianco; G., Tortora
8-Cl-cAMP in differentiation therapy: The reversal and suppression of malignancy targeting the intracellular transducing proteins of cAMP. 1-gen-1991 Y. S., Cho Cgung; H., Yokozaki; G., Tortora; Pepe, Stefano; T., Clair
A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN) 1-gen-2005 F., Caponigro; G., Franchin; V., Rav; G., Silvestro; B., Morrica; C., Romano; E., Minatel; Pepe, Stefano
A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. 1-gen-2008 F., Caponigro; C., Romano; A., Milano; R., Solla; G., Franchin; V., Adamo; E., Mari; B., Morrica; Pepe, Stefano
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FLFOX-4) as first-line treatment of advanced gastric cancer patients. 1-gen-2004 F., De Vita; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., De Placido; G., Galizia; F., Ciardiello; G., Catalano; A. R., Bianco
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. 1-gen-2005 F., DE VITA; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., DE PLACIDO; G., Galizia; N., DI MARTINO; F., Ciardiello; G., Catalano; A. R., Bianco
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 1-gen-2020 Sabbatino, Francesco; Polcaro, Giovanna; Liguori, Luigi; Manzo, Valentina; Conti, Valeria; Col, Jessica Dal; Vergatti, Anita; Stellato, Cristiana; Casolaro, Vincenzo; Filippelli, Amelia; Ferrone, Soldano; Pepe, Stefano
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 1-gen-2014 Sabbatino, Francesco; Wang, Yangyang; Wang, Xinhui; Flaherty, Keith T.; Pepin, David; Scognamiglio, Giosuè; Yu, Ling; Cooper, Zachary A.; Pepe, Stefano; Kirkwood, John M.; Frederick, Dennie T.; Wargo, Jennifer A.; Ferrone, Soldano; Ferrone, Cristina R.
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma 1-gen-2016 Sabbatino, Francesco; Wang, Yangyang; Scognamiglio, Giosuè; Favoino, Elvira; Feldman, Steven A.; Villani, Vincenzo; Flaherty, Keith T.; Nota, Sjoerd; Giannarelli, Diana; Simeone, Ester; Anniciello, Anna M.; Palmieri, Giuseppe; Pepe, Stefano; Botti, Gerardo; Ascierto, Paolo A.; Ferrone, Cristina R.; Ferrone, Soldano
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study. 1-gen-2007 G., DI LORENZO; A., Rea; C., Carlomagno; Pepe, Stefano; G., Palmieri; R., Labianca; A., Chirianni; A., DE STEFANO; V., Esposito; S., DE PLACIDO; V., Montesarchio
ADDITION OF ERLOTINIB TO FLUROPYRIMIDINE-OXALIPLATIN-BASED CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB: TWO SEQUENTIAL PHASE I TRIALS. 1-gen-2011 C., Carlomagno; G., Daniele; R., Baianco; R., Marciano; V., Damiano; E., Matano; L., Nappi; Pepe, Stefano; S., DE PLACIDO; G., Tortora
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-a genes on in vitro transformation of human mammary epithelial cells. 1-gen-1992 F., Ciardiello; M., Gottardis; F., Basolo; Pepe, Stefano; N., Normanno; R. B., Dickson; A. R., Bianco; D. S., Salomon
Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom? 1-gen-2014 A., De Stefano; R., Moretto; L., Bucci; Pepe, Stefano; F. J., Romano; A. C., Cella; L., Attademo; M., Rosanova; S., De Falco; G., Fiore; L., Raimondo; S., De Placido; C., Carlomagno
Adjuvant treatment of diabetic foot 1-gen-2012 Lo Pardo, D; Pezzuti, G; Selleri, Carmine; Pepe, Stefano; Esposito, Silvano
Altre Neoplasie 1-gen-2007 Pepe, Stefano; A., Contegiacomo; E., Matano
Altre Neoplasie. 1-gen-1999 Pepe, Stefano; A., Contegiacomo; E., Matano
Analysis of Differential miRNA Expression in Primary Tumor and Stroma of Colorectal Cancer Patients 1-gen-2014 G., Della Vittoria Scarpati; E., Calura; M., Di Marino; C., Romualdi; L., Beltrame; U., Malapelle; G., Troncone; A., De Stefano; Pepe, Stefano; S., De Placido; M., D'Incalci; S., Marchini; C., Carlomagno
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. 1-gen-1997 A., DE LUCA; M. P., Selvam; C., Sandomenico; Pepe, Stefano; A. R., Bianco; F., Ciardiello; D. S., Salomon; N., Normanno
Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment. 1-gen-1999 Y. S., CHO CHUNG; M., Nesterova; Pepe, Stefano; G. R., Lee; K., Noguchi; R. K., Srivastava; A. R., Srivastrava; O., Alper; Y. G., Park; Y. N. L. E., E.